Clinical Trial Update: Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nivolumab with ipilimumab followed by nivolumab monotherapy as first-line treatment for advanced melanoma has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2021-06-15